None
Quote | Akebia Therapeutics Inc. (NASDAQ:AKBA)
Last: | $0.9357 |
---|---|
Change Percent: | 0.69% |
Open: | $0.94 |
Close: | $0.9357 |
High: | $0.945 |
Low: | $0.91 |
Volume: | 1,778,817 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Akebia Therapeutics Inc. (NASDAQ:AKBA)
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference PR Newswire CAMBRIDGE, Mass. , June 27, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purp...
2024-06-24 09:37:22 ET More on Akebia Buy Vafseo's Approval: A New Chapter For Akebia Therapeutics In Anemia Management Akebia's Vafseo Faces Grim Market Outlook (Rating Downgrade) Read the full article on Seeking Alpha For further details see: Akebia The...
Message Board Posts | Akebia Therapeutics Inc. (NASDAQ:AKBA)
Subject | By | Source | When |
---|---|---|---|
Nice rise from .50s past few weeks. Pump | tw0122 | investorshub | 04/28/2023 11:22:27 AM |
Bought a lot here today. | Afterhoursearnings3 | investorshub | 03/09/2023 7:44:45 PM |
two hedge funds competing to be largest $AKBA | shurtha2000 | investorshub | 03/02/2023 4:04:38 PM |
Nice find G2G. :) | subslover | investorshub | 02/24/2023 12:57:07 PM |
$AKBA 2NEWS 2DAY | TheFinalCD | investorshub | 02/24/2023 12:12:44 AM |
News, Short Squeeze, Breakout and More Instantly...
Akebia Therapeutics Inc. Company Name:
AKBA Stock Symbol:
NASDAQ Market:
Akebia Therapeutics Inc. Website:
Akebia Therapeutics to Present at the H.C. Wainwright 3rd Annual Kidney Virtual Conference PR Newswire CAMBRIDGE, Mass. , June 27, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purp...
Akebia Therapeutics Appoints Erik Ostrowski as Chief Financial Officer and Chief Business Officer PR Newswire CAMBRIDGE, Mass. , June 24, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with t...
Akebia Therapeutics to Present at the Jefferies Global Healthcare Conference PR Newswire CAMBRIDGE, Mass. , May 23, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better t...